Vertex Pharmaceuticals Inc. buy Citigroup Inc.
Start price
10.03.26
/
50%
€435.00
Target price
10.03.27
€503.22
Performance (%)
-11.20%
Price
31.03.26
€386.30
Summary
This prediction is currently active. The prediction for Vertex Pharmaceuticals Inc. disappoints with a performance of -11.20%. This prediction currently runs until 10.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Vertex Pharmaceuticals Inc. | -1.088% |
| iShares Core DAX® | 0.751% |
| iShares Nasdaq 100 | -1.405% |
| iShares Nikkei 225® | 0.417% |
| iShares S&P 500 | -0.590% |
Comments by Citigroup_Inc_ for this prediction
In the thread Vertex Pharmaceuticals Inc. diskutieren
Vertex Pharmaceuticals (VRTX) had its price target raised by Citigroup Inc. from $575.00 to $585.00. They now have a "buy" rating on the stock.
Ratings data for VRTX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Vertex Pharmaceuticals Inc.
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€346.50
02.10.25
02.10.25
€489.84
02.10.26
02.10.26
11.49%
31.03.26
31.03.26
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€470.80
14.11.24
14.11.24
€545.96
14.11.25
14.11.25
-19.47%
15.11.25
15.11.25